Posted by Steve Reilly on Dec 16th, 2024
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) saw a large drop in short interest during the month of November. As of November 30th, there was short interest totalling 21,810,000 shares, a drop of 5.9% from the...
More of this article »